Home | Sitemap | Search | ContactA- A A+
   
 
    Public Member Support us  
 

Trial II 

CMF + prednisone combined with or without oophorectomy for pre/perimenopausal patients with breast cancer and 4 or more positive nodes.

DESIGN

Design Trial II

Results & Publications


Presentations


Publications

Study Chair
Prof. Aron Goldhirsch - Milano, Italy

Statistician

Karen Price

Lead Trial Coordinators
Holly Shaw

Director of Data Management
Lynette Blacher

IBCSG Data Management Center/FSTRF
4033 Maple Road
Amherst, New York 14226 USA
Phone: +1 716 834 0900
Fax: +1 716 833 3990

Email: ibcsgI-IV@fstrf.org

Date of Activation
July 1, 1978

Date of Closure
September 1, 1981

Final Accrual
1713 patients (1601 evaluable patients)


Results Publications Results & Publications


News

09.09.2018:
9.9.2018 - RACE FOR LIFE, Bundesplatz Bern

23.03.2018:
The next IBCSG Annual Meeting will take place in Barcelona, Spain on March 23 and 24, 2018

04.10.2017:
IBCSG Slide Deck ESMO 2017 available now

All News

 
  Print